Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why

Mohd Haider
September 17, 2025

AquaBounty Technologies Inc. (NASDAQ:AQB) experienced explosive after-hours trading on Wednesday, with shares jumping 98.25% to $2.26 after closing at $1.14 during regular trading hours.

Check out the current price of AQB stock here.

NASDAQ Compliance Milestone Drives Rally

The biotech company’s significant after-hours jump came after it was confirmed that it met NASDAQ's minimum bid price requirement. A Securities and Exchange Commission Form 8-K filed on Wednesday revealed that AquaBounty had received official confirmation from NASDAQ's Listing Qualifications Department that the delisting issue had been resolved.

Delisting Risk Resolved

The company previously faced delisting risk when its stock price fell below $1.00 per share for 30 consecutive business days, triggering a compliance violation in January.

See Also: BlackRock-Backed Minute Media Buys $250M Indian AI Startup That Turns Sports Into Instant Viral Content

Interim CEO David A. Frank signed the compliance notification filing for the Massachusetts-based company.

Technical Trading Metrics Signal Volatility

AquaBounty’s stock has gained 80.95% so far in 2025. On September 4th, it peaked at $1.28 with a volume of 2.1 million shares. Yesterday, it closed at $1.14 with a significantly higher volume of 14 million shares, showing a decrease of about 10.94% from its peak.

With a market capitalization of $4.42 million and average daily volume of 4.24 million shares, AquaBounty has a 52-week range of $0.47-$1.62.

Price Action: According to Benzinga Pro data, AQB’s regular session performance showed modest gains of 0.88% on Wednesday.

Benzinga’s Edge Stock Rankings highlight that AQB has a Momentum score of 83.97. Track the performance of other players in this segment.

Read Next:

  • Bitcoin Unmoved By Fed Rate Cut; Ethereum, XRP, Dogecoin Spike: Analyst Says BTC Should See $120,000 By End Of Week If ‘All Goes To Plan’

Photo Courtesy: Miha Creative on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Continue Reading...

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

A robot programmed to act like a 7-year-old girl works to combat fear and loneliness in hospitals

Days after Meagan Brazil-Sheehan’s 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass Memorial Children’s Medical Center when they ran into Robin the Robot.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint

SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Warner Bros. Discovery Stock Takes Off As Paramount Skydance Eyes Takeover

Warner Bros. Discovery's stock jumps more than 28% on Thursday—its biggest single-day gain ever.

Carney Cuts The Red Tape, Unveils Over $43 Billion In Flagship Projects

PM Mark Carney announces first projects to be reviewed by Canada's new Major Projects Office, aiming to cut red tape and attract investments.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

Oracle Stock Is Rallying To Start The Week: What's Driving The Momentum?

Oracle Corporation (NASDAQ: ORCL) shares are trading higher and trending on Monday. Here's a look at what's going on.

The Next Evolution in Public Treasuries - Ad

MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz

On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Now summer's over, here's what to do with all those photos on your camera roll

LONDON (AP) — The summer holidays are over, and all those great times you had on vacation have been memorialized in hundreds of smartphone photos. Now what?

Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust

WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.

The First Public Cash-Flowing Digital Treasury - Ad

Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.

Bitcoin, Ethereum, Dogecoin Hold Steady As XRP Slips Ahead Of PPI Data

Cryptocurrency markets opened Wednesday on a cautious note, trading slightly lower ahead of the latest U.S. Producer Price Index (PPI) data release.

Family says a man who died after going on a Universal roller coaster never let wheelchair stop him

ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

FDA Approval Could Send This Stock Soaring - Ad

Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.

California Gov. Gavin Newsom extends signature program aimed at curbing carbon emissions

SACRAMENTO, Calif. (AP) — California Gov. Gavin Newsom on Friday extended a signature state program aimed at reducing planet-warming emissions through 2045, a move Democrats cheered but Republicans warned would raise gas prices.

Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto

The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company's focus on growth opportunities in obesity and diabetes medications.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

EU lays out new tariffs and sanctions on Israel over war in Gaza

BRUSSELS (AP) — The European Union laid out Wednesday its toughest plan yet to pressure Israel to end the war in Gaza as from Israeli tanks, drones and troops pushing deeper into the coastal enclave ravaged by 23 months of war.

European Central Bank expected to keep rates on hold as economy weathers Trump's tariffs

FRANKFURT, Germany (AP) — Inflation is back under control, and the European economy is weathering Trump's tariff onslaught better than expected. Those are reasons the European Central Bank is expected to keep its benchmark interest rate unchanged Thursday.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

AP Exclusive: Russia, Vietnam using energy profits to avoid possible US sanctions for arms deals

BANGKOK (AP) — Russia and Vietnam have developed a back-door method of concealing arms deal payments to avoid American and other Western sanctions, using the profits from joint oil and gas ventures to pay off defense contracts without any open transfers of cash through the global banking system, according to internal Vietnamese documents obtained by The Associated Press.

Elon Musk's xAI Reportedly Lays Off 500 Workers From Data Annotation Team As Startup Pivots To Specialist AI Tutors For Grok Expansion

Elon Musk's xAI has laid off about 500 data annotators in a major restructuring, shifting focus to specialist AI tutors to accelerate Grok's development despite recently securing $10 billion in new funding.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

US official sees Greece as hub to boost American natural gas exports

ATHENS, Greece (AP) — A U.S. Cabinet official overseeing a planned expansion of natural gas exports to Europe said Thursday that could play a key role through its pipeline system that extends across the region.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Trump's H-1B Visa Plan Stuns Big Tech, White House Says $100,000 Fee Is One-Time Only

The White House clarified that the $100,000 H-1B visa fee is a one-time charge, not an annual fee, amid confusion among major tech companies.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service